SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.

SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.
复制标题

DOI:
10.1016/j.ccr.2010.06.018
复制
发表时间:
2010-08-09
期刊:
影响因子:
50.3
通讯作者:
Bast RC Jr
Bast RC Jr
中科院分区:
医学1区
文献类型:
--
作者:
Ahmed AA;Lu Z;Jennings NB;Etemadmoghadam D;Capalbo L;Jacamo RO;Barbosa-Morais N;Le XF;Australian Ovarian Cancer Study Group;Vivas-Mejia P;Lopez-Berestein G;Grandjean G;Bartholomeusz G;Liao W;Andreeff M;Bowtell D;Glover DM;Sood AK;Bast RC Jr

文献摘要

参考文献

被引文献

相似文献

有丝分裂调节因子已成功地被靶向增强对紫杉烷化疗的反应。在这里,我们发现盐诱导蛋白2(SIK2)定位于中心体,在有丝分裂的启动中起关键作用,并通过S2392的磷酸化调节中心体连接蛋白C-NAP1的定位。干扰已知的SIK2抑制剂PKA诱导SIK2依赖的中心体分裂在间期,而SIK2缺失阻止有丝分裂中的中心体分离,在培养和异种移植中使卵巢癌对紫杉醇增敏。SIK2的缺失也延迟了G1/S的转变,降低了AKT的磷酸化。在高级别浆液性卵巢癌患者中,SIK2的高表达与患者的低生存率显著相关。这些数据表明,SIK2可能是卵巢癌治疗的靶点。
Regulators of mitosis have been successfully targeted to enhance response to taxane chemotherapy. Here, we show that the Salt Inducible Kinase 2 (SIK2) localizes at the centrosome, plays a key role in the initiation of mitosis and regulates the localization of the centrosome linker protein, C-Nap1, through S2392 phosphorylation. Interference with the known SIK2 inhibitor PKA induced SIK2-dependent centrosome splitting in interphase while SIK2 depletion blocked centrosome separation in mitosis, sensitizing ovarian cancers to paclitaxel in culture and in xenografts. Depletion of SIK2 also delayed G1/S transition and reduced AKT phosphorylation. Higher expression of SIK2 significantly correlated with poor survival in patients with high-grade serous ovarian cancers. These data identify SIK2 as a plausible target for therapy in ovarian cancers.
DOI: 10.1093/jnci/83.11.757
发表时间: 1991-06-05
期刊: JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子: --
作者:
MONKS, A;SCUDIERO, D;BOYD, M
通讯作者: BOYD, M
DOI: 10.1093/jnci/djn151
发表时间: 2008-06-04
影响因子: 10.3
作者:
Martin, Miguel;Rodriguez-Lescure, Alvaro;Manuel Lopez-Vega, Jose
通讯作者: Manuel Lopez-Vega, Jose
DOI: 10.1111/j.1742-4658.2006.05291.x
发表时间: 2006-06-01
期刊: FEBS JOURNAL
影响因子: 5.4
作者:
Katoh, Yoshiko;Takemori, Hiroshi;Okamoto, Mitsuhiro
通讯作者: Okamoto, Mitsuhiro
DOI: 10.1016/j.ccr.2007.11.014
发表时间: 2007-12
期刊: Cancer cell
影响因子: 50.3
作者:
Ahmed AA;Mills AD;Ibrahim AE;Temple J;Blenkiron C;Vias M;Massie CE;Iyer NG;McGeoch A;Crawford R;Nicke B;Downward J;Swanton C;Bell SD;Earl HM;Laskey RA;Caldas C;Brenton JD
通讯作者: Brenton JD
DOI: 10.1158/0008-5472.can-05-2925
发表时间: 2006-02-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
O'Reilly, KE;Rojo, F;Rosen, N
通讯作者: Rosen, N